{"symbol":"LLY","fiscalQuarter":"Q3-2009","reportDate":"2009-10-21","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q3-2009","postBrief":{"headline":"Eli Lilly Misses on EPS, Stock Down 4.5%","keyNumbers":[{"metric":"EPS","actual":"$0.86","expected":"N/A","surprise":"-15.52%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management acknowledged the challenges faced during the quarter.","They emphasized a focus on long-term strategies despite the current results."],"summary":"Management expressed concerns about the recent performance and highlighted the need for strategic adjustments. They did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Eli Lilly's earnings report indicates a disappointing quarter with a notable EPS miss, which contributed to a 4.5% decline in stock price. Investors may be concerned about the company's ability to meet expectations moving forward, especially given the lack of guidance. The management's defensive tone suggests they are aware of the challenges ahead and are focusing on long-term strategies.","metaDescription":"Eli Lilly (LLY) Q3 2009 earnings: EPS missed expectations. Stock down 4.5%. Full breakdown."}}